Exploring the impact of a digital health tool on patients' interaction with community pharmacists: A pilot randomized controlled study

被引:0
|
作者
Qudah, Bonyan [1 ]
Chewning, Betty [2 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, 1685 Highland Ave, Madison, WI 53705 USA
[2] Univ Wisconsin, Sch Pharm, Dept Social & Adm Sci, 777 Highland Ave, Madison, WI 53705 USA
来源
关键词
Patient-reported outcomes; Digital health intervention; Patient participation; Patient-pharmacist communication; Patient concerns; Medication-related problems; Community pharmacy; MEDICAL CONSULTATIONS; COMMUNICATIVE STYLES; ADHERENCE; PARTICIPATION; QUESTION; KNOWLEDGE; BARRIERS; OUTCOMES; THERAPY; ISSUES;
D O I
10.1016/j.sapharm.2024.06.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The use of digital Patient- Reported Outcomes (PRO) tools has been shown to enhance the exchange of information and shared decision-making in medical encounters. However, their influence on patient-pharmacist interactions has not yet been explored. Objectives: This study aimed to examine the impact of RxTalk (TM), a digital PRO tool, in supporting the communication between patients and pharmacists compared to usual care. Methods: Intervention: RxTalk (TM) was developed to collect information about medication adherence and beliefs, using a tablet computer. Study design: A pilot randomized controlled study was conducted at a community pharmacy in Wisconsin, USA. Sixty patients were randomized to either the intervention group who used RxTalk (TM) during medication pick-up or the control group who did not use the tool. Patients who used RxTalk (TM) received paper copies of their responses which were also shared with pharmacists. The consultation was audio-recorded for both groups and coded using the Active Patient Participation Coding scale. Follow-up phone interviews were conducted with both groups within one week of enrollment. Results: Patient tapes were analyzed. In the unadjusted model, patients in the intervention group had a higher active participation rate (p = 0.004) and raised significantly more concerns during consultations (p < 0.001) compared to the control group. Pharmacists asked twice as many questions while counseling patients in the intervention group compared to the control group (p < 0.001). After controlling for patients' demographics and pharmacists' questions, there was a statistical difference between the two patient groups in their odds of expressing at least one concern utterance. Conclusion: This pilot study suggests that collecting PRO from patients with chronic illnesses and providing results to pharmacists and patients can help patients express their health and medication concerns. RxTalk (TM) would be useful for pharmacists who wish to improve the recognition and management of medication-related problems.
引用
收藏
页码:986 / 994
页数:9
相关论文
共 50 条
  • [31] The effects of a digital lifestyle intervention in patients with hypertension: Results of a pilot randomized controlled trial
    Wildenauer, Alina
    Maurer, Leonie Franziska
    Roetzer, Laurin
    Eggert, Torsten
    Schoebel, Christoph
    JOURNAL OF CLINICAL HYPERTENSION, 2024, 26 (08): : 902 - 911
  • [32] Involvement of community pharmacists on attention-deficit/hyperactivity disorder patients. A pilot study
    Palomino, M. D.
    Martin-Calero, M. J.
    Marques, G.
    PHARMACEUTICAL CARE ESPANA, 2012, 14 (05): : 183 - 192
  • [33] Crowdsourcing integrated into a digital mental health platform for anxiety and depression: A pilot randomized controlled trial
    Kaveladze, Benjamin
    Shkel, Jane
    Le, Stacey
    Marcotte, Veronique
    Rushton, Kevin
    Nguyen, Theresa
    Schueller, Stephen M.
    INTERNET INTERVENTIONS-THE APPLICATION OF INFORMATION TECHNOLOGY IN MENTAL AND BEHAVIOURAL HEALTH, 2024, 38
  • [34] Patients' perception of community pharmacists as healthcare providers and willingness to participate in pharmacist services: a pilot study
    Ekenga, Vincent
    Bailey-Wheeler, Janel
    Sarpong, Daniel
    Hart, Tammy
    Earls, Martha
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2018, 9 (04) : 297 - 300
  • [35] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Xavier Pourrat
    Clarisse Roux
    Brigitte Bouzige
    Valérie Garnier
    Armelle Develay
    Benoit Allenet
    Martial Fraysse
    Jean-Michel Halimi
    Jacqueline Grassin
    Bruno Giraudeau
    Trials, 15
  • [36] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Allenet, Benoit
    Fraysse, Martial
    Halimi, Jean-Michel
    Grassin, Jacqueline
    Giraudeau, Bruno
    TRIALS, 2014, 15
  • [37] Impact of a Digital Tool on Pharmacy Students' Ability to Perform Medication Reviews: A Randomized Controlled Trial
    Dabidian, Armin
    Obarcanin, Emina
    Sherazi, Bushra Ali
    Schlottau, Sabina
    Schwender, Holger
    Laeer, Stephanie
    HEALTHCARE, 2023, 11 (13)
  • [38] Acupuncture in patients with chronic migraine - a randomized controlled trial - a pilot study
    Yang, C-P
    CEPHALALGIA, 2009, 29 : 160 - 161
  • [39] Impact of Acupuncture on Vasomotor Rhinitis: A Randomized Placebo-Controlled Pilot Study
    Fleckenstein, Johannes
    Raab, Cornelia
    Gleditsch, Jochen
    Ostertag, Peter
    Rasp, Gerd
    Stoer, Wolfram
    Irnich, Dominik
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2009, 15 (04) : 391 - 398
  • [40] Administration of albumin in hypoalbuminemic patients - A prospective, randomized, controlled, pilot study
    Dubois, MJ
    Orellana-Jimenez, C
    Melot, C
    De Backer, D
    Berre, J
    Leeman, M
    Brimiouille, S
    Appoloni, O
    Creteur, J
    Vincent, JL
    CRITICAL CARE MEDICINE, 2002, 30 (12) : A108 - A108